Learn more about our Diagnostics work.
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19). …
On March 5, 2020, the VALID Act was introduced in the Senate and House.
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the…
AdvaMedDx® Test to Treatment fact sheets and social media-ready value facts communicate the value of diagnostics.
LAB Act (H.R. 3584) would delay PAMA reporting period in order to improve data collection process for market-based rates WASHINGTON, D.C. — With 53 million Americans facing steep year-over-year cuts…
Washington, D.C. – As part of a renewed push to advance comprehensive diagnostic reform, more than 80 leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers…
WASHINGTON, D.C. – AdvaMedDx®, a division of the Advanced Medical Technology Association® (AdvaMed®) that focuses on the value diagnostics bring to patients’ health and health care, today announced that Phi…
Leading Health Groups Challenge GAO’s Flawed Report on Medicare Lab Billing February 25, 2019 Washington, D.C. – In response to broad and misleading claims in a recent Government Accountability…